Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RLAY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 753 | $18.62 | $14.0K Sale | Form 4 ↗ |
| Oct 28, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 2,252 | $18.62 | $41.9K Sale | Form 4 ↗ |
| Oct 28, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,469 | $18.62 | $27.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 8,530 | $18.97 | $161.8K Sale | Form 4 ↗ |
| Sep 8, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $18.94 | $335.6K Sale | Form 4 ↗ |
| Sep 8, 2026 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 48,199 | $18.94 | $912.9K Sale | Form 4 ↗ |
| Aug 26, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 4,508 | $20.03 | $90.3K Sale | Form 4 ↗ |
| Aug 25, 2026 | SB Investment Advisers (UK) Ltd 10% owner | RLAY Relay Therapeutics, Inc. | Sale | 6.00M | $19.40 | $116.4M Sale | Form 4 ↗ |
| Aug 17, 2026 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 48,199 | $20.33 | $979.9K Sale | Form 4 ↗ |
| Aug 14, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $19.74 | $349.7K Sale | Form 4 ↗ |
| Jul 28, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,459 | $18.61 | $27.2K Sale | Form 4 ↗ |
| Jul 28, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 748 | $18.61 | $13.9K Sale | Form 4 ↗ |
| Jul 28, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 2,237 | $18.61 | $41.6K Sale | Form 4 ↗ |
| Jul 7, 2026 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 48,199 | $19.58 | $943.7K Sale | Form 4 ↗ |
| Jul 6, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 8,660 | $18.71 | $162.0K Sale | Form 4 ↗ |
| Jul 6, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $18.69 | $331.1K Sale | Form 4 ↗ |
| Jun 30, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 50,000 | $19.09 | $954.5K Sale | Form 4 ↗ |
| Jun 22, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 51,560 | $16.97 | $875.0K Sale | Form 4 ↗ |
| Jun 22, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 61,563 | $16.97 | $1.0M Sale | Form 4 ↗ |
| Jun 22, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 56,323 | $16.97 | $955.8K Sale | Form 4 ↗ |
| Jun 22, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $17.01 | $301.4K Sale | Form 4 ↗ |
| Jun 22, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 93,456 | $16.94 | $1.6M Sale | Form 4 ↗ |
| May 14, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $12.86 | $227.8K Sale | Form 4 ↗ |
| Apr 28, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 972 | $14.79 | $14.4K Sale | Form 4 ↗ |
| Apr 28, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 753 | $14.79 | $11.1K Sale | Form 4 ↗ |
| Apr 28, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 1,490 | $14.79 | $22.0K Sale | Form 4 ↗ |
| Apr 9, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,800 | $15.00 | $27.0K Sale | Form 4 ↗ |
| Apr 7, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $13.01 | $230.5K Sale | Form 4 ↗ |
| Mar 9, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 17,717 | $10.06 | $178.2K Sale | Form 4 ↗ |
| Jan 28, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 2,686 | $8.45 | $22.7K Sale | Form 4 ↗ |
| Jan 28, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 1,354 | $8.45 | $11.4K Sale | Form 4 ↗ |
| Jan 28, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,695 | $8.45 | $14.3K Sale | Form 4 ↗ |
| Jan 27, 2026 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 18,895 | $7.62 | $144.0K Sale | Form 4 ↗ |
| Jan 27, 2026 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 11,684 | $7.62 | $89.0K Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 13,820 | $7.62 | $105.3K Sale | Form 4 ↗ |
| Jan 6, 2026 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 43,168 | $7.82 | $337.6K Sale | Form 4 ↗ |
| Nov 3, 2025 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 62,073 | $7.00 | $434.5K Sale | Form 4 ↗ |
| Oct 29, 2025 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 21,394 | $7.50 | $160.5K Sale | Form 4 ↗ |
| Oct 28, 2025 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 19,135 | $7.29 | $139.5K Sale | Form 4 ↗ |
| Oct 28, 2025 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 21,664 | $7.29 | $157.9K Sale | Form 4 ↗ |
| Oct 28, 2025 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 30,897 | $7.29 | $225.2K Sale | Form 4 ↗ |
| Jul 29, 2025 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 15,724 | $3.68 | $57.9K Sale | Form 4 ↗ |
| Jul 29, 2025 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 18,380 | $3.68 | $67.6K Sale | Form 4 ↗ |
| Jul 29, 2025 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 26,701 | $3.68 | $98.3K Sale | Form 4 ↗ |
| Jul 29, 2025 | Brian Adams Chief Legal Officer | RLAY Relay Therapeutics, Inc. | Sale | 18,276 | $3.68 | $67.3K Sale | Form 4 ↗ |
| Jul 28, 2025 | Peter Rahmer See remarks | RLAY Relay Therapeutics, Inc. | Sale | 1,359 | $3.74 | $5,083 Sale | Form 4 ↗ |
| Jul 28, 2025 | Thomas Catinazzo Chief Financial Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,701 | $3.74 | $6,362 Sale | Form 4 ↗ |
| Jul 28, 2025 | Donald A. Bergstrom President, R&D | RLAY Relay Therapeutics, Inc. | Sale | 4,069 | $3.74 | $15.2K Sale | Form 4 ↗ |
| Jul 28, 2025 | Brian Adams Chief Legal Officer | RLAY Relay Therapeutics, Inc. | Sale | 1,637 | $3.74 | $6,122 Sale | Form 4 ↗ |
| Jul 9, 2025 | Sanjiv Patel President and CEO, Director | RLAY Relay Therapeutics, Inc. | Sale | 18,639 | $3.57 | $66.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances